Voprosy meditsinskoi khimii (ISSN 0042-8809)

Potentiation of the antiketogenic effect of exogenous glucose with the help of the new beta-oxidation inhibitor mildronate--3-(2,2,2-trimethylhydrazine)propionate

   
Shutenko Zh.V., Meirena D.V., Kalvin'sh I.Ia., Lukevits E.Ia.
PubMed Id: 1897198
Year: 1991 vol: 37  issue:2  pages: 59-60
Abstract: Antiketogenic effect of exogenous glucose (2 g/kg, per os, 1 hr before death) was potentiated after preadministration of mildronate 3-(2,2,2-trimethylhydrazinium) propionate into rats either kept on usual ration or fasting within 48 hrs at a dose of 200 and 400 mg/kg, per os, during 10 days. Mildronate is inhibitor of carnitine-dependent metabolism of fatty acids affecting at the step of gamma-butyrobetaine turnover into carnitine. The drug inhibitory influence studied appears to be realized via activation of the glycolytic pathway of glucose metabolism specific for inhibitors of beta-oxidation.
Download PDF:
Reference: Shutenko Zh.V., Meirena D.V., Kalvin'sh I.Ia., Lukevits E.Ia., Potentiation of the antiketogenic effect of exogenous glucose with the help of the new beta-oxidation inhibitor mildronate--3-(2,2,2-trimethylhydrazine)propionate, Voprosy meditsinskoi khimii, 1991, vol: 37(2), 59-60.
References
 1995(Vol:41)
 1994(Vol:40)
 1993(Vol:39)
 1992(Vol:38)
 1991(Vol:37)
 1990(Vol:36)
 1989(Vol:35)
 1988(Vol:34)
 1987(Vol:33)
 1986(Vol:32)